Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Juno Medical, the modern doctor's office that's designed for the 99%, today announced $12 million in Series A funding co-led by Julian Eison, Managing...
-
WASHINGTON, DC, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Emergency physicians around the country are treating patients with a range of respiratory emergencies caused by the “triple threat” of severe cases...
-
LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research on the renal biomarkers market, the rise in geriatric and paediatric renal patients is expected to...
-
New York, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The REACH Institute, a 501c3 nonprofit dedicated to ensuring the most effective, scientifically proven mental health care reaches all children and...
-
Chicago, Dec. 08, 2022 (GLOBE NEWSWIRE) -- According to the new market research report " the global industrial hemp market size valued at USD 6.8 billion in 2022 and is estimated to reach USD 18.1...
-
New York, USA, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Dental Anesthesia Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Dental Anesthesia Market...
-
New York, USA, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Biosimilars Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Biosimilars Market Information By...
-
NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and...
-
York, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a...
-
NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of...